JN1517 重组人IL-22

我公司致力于为客户提供高纯度、低成本的活性重组蛋白，包括重组人IL-22在内的各类受体、细胞因子、生长因子、转录因子、激素、酶、毒性蛋白、病毒抗原等。...

特别提示：包括重组人IL-22(C端带IgG2 Fc标签)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人IL-22(C端带IgG2 Fc标签)
英文名称：Recombinant Human Interleukin-22
产品货号：JN1517
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ala34-Ile179在C端带hIgG2 Fc标签。

IL-22质量控制：＞95%(还原性SDS-PAGE)

IL-22制剂：冻干品

IL-22保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

IL-22复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于IL-22：
Interleukin-22(IL-22) is a member of a group of the IL-10 family, a class of potent mediators of cellular inflammatory responses. IL-22 is produced by activated DC and T cells. IL-22 and IL-10 receptor chains play a role in cellular targeting and signal transduction. It can initiate and regulate innate immune responses against bacterial pathogens especially in epithelial cells such as respiratory and gut epithelial cells. IL-22 along with IL-17 likely plays a role in the coordinated response of both adaptive and innate immune systems. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10. Biological activity of IL-22 is initiated by binding to a cell-surface complex consisting of IL-22R1 and IL-10R2 receptor chains. IL-22 biological activity is further regulated by interactions with a soluble binding protein, IL-22BP. IL-22BP and an extracellular region of IL-22R1 share sequence similarity. In some cases, the pro-inflammatory versus tissue-protective functions of IL-22 are regulated by cytokine IL-17A.

根据您的关注的重组人IL-22(C端带IgG2 Fc标签)，重组人IL-22，rIL-22，重组IL-22，重组人Interleukin-22，重组Interleukin-22，rInterleukin-22，rhInterleukin-22，rhIL-22，Recombinant Human Interleukin-22，您可能还对以下产品有需求：


JN0228 重组人酸性FGF1(成纤维细胞生长因子1) 10μg|50μg|500μg|1mg
JN0483 重组小鼠疱疹病毒侵入介质(HVEM)(TNFRSF14) 10μg|50μg|500μg|1mg
JN1914 重组人碳酸酐酶XIII(CA13) 10μg|50μg|500μg|1mg
JN0533 重组人迁移率族蛋白B1(HMGB1) 10μg|50μg|500μg|1mg
JN0535 重组人连接粘附分子B(JAM-B) 10μg|50μg|500μg|1mg
JN0553 重组人顶体蛋白SP-10 10μg|50μg|500μg|1mg
JN0625 重组人载脂蛋白M(ApoM) 10μg|50μg|500μg|1mg

关注重组人IL-22(C端带IgG2 Fc标签)，重组人IL-22，rIL-22，重组IL-22，重组人Interleukin-22，重组Interleukin-22，rInterleukin-22，rhInterleukin-22，rhIL-22，Recombinant Human Interleukin-22的同时，为您推荐更多您可能感兴趣的产品：



名称：重组人趋化因子CXCL14(BRAK)
货号：JN0291
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备，目的基因编码的Ser35-Glu111表达纯化而来。

CXCL14/BRAK质量控制：＞95%(还原性SDS-PAGE)。

CXCL14/BRAK制剂：冻干品

CXCL14/BRAK保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

CXCL14/BRAK复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于CXCL14/BRAK：
Human Chemokine (C-X-C Motif) Ligand 14 (CXCL14) is constitutively expressed in certain normal tissues but is reduced or absent from many established tumor cell lines and human cancers. CXCL14 is known to be a chemoattractant for monocyte and dendritic cells. CXCL14 inhibits angiogenesis and exhibits antimicrobial activities. Mature human and mouse CXCL14 differ by only 2 amino acid residues.

名称：重组人趋化因子CCL28
货号：JN0304
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备，目的基因编码的Ile20-Tyr127表达纯化而来。

CCL28质量控制：＞95%(还原性SDS-PAGE)。

CCL28制剂：冻干品

CCL28保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

CCL28复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于CCL28：
Chemokine (C-C Motif) Ligand 28 (CCL28) is a novel chemokine that shares the most homology with CCL27/CTACK. CCL28 shows chemotactic activity for resting CD4, CD8 T-cells and eosinophils. It Binds to CCR3 and CCR10 and induces calcium mobilization in a dose-dependent manner. CCR10 (GPR2 orphan receptor) is also the receptor for CCL27/CTACK. CCL28 is preferentially expressed by epithelial cells of diverse tissues, with highest expression level in normal and pathological colon. It is also expressed in normal and asthmatic lung tissues. Human and mouse CCL28 shares 83% sequence identity in their mature regions

如果您觉得“JN1517 重组人IL-22”描述资料不够齐全，请联系我们获取详细资料。(联系时请告诉我从仪器交易网看到的，我们将给您最大优惠！)
本页链接：http://www.yi7.com/com_bjbiolab/sell/itemid-8554376.html
已经有804位访客查看了本页.